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CHAPTER 1 
 
 
 
INTRODUCTION 
 
 
 
Overview 
 
 Cardiovascular defects are the most common congenital abnormality in the human 
population, affecting approximately one out of every 100 live births worldwide (J. 
Hoffman, 2002).  Defects in valve development account for 25-30% of these 
malformations, therefore being responsible for the majority of morbidity and mortality 
that occurs in association with abnormal heart development.  It is thought that subtle 
cardiac developmental anomalies as well as some genetic predispositions can be linked to 
adult-onset heart disease.  Despite advances in surgical techniques such as the Ross 
procedure (replacing the aortic valve with the patient’s pulmonary valve) and 
implantation of artificial valves, valvular insufficiency remains difficult to treat.  Most 
notably, such procedures are limited to short-term resolution of the overlying valve 
insufficiency.  Synthetic valve replacement may be effective in elderly patients, however, 
use in infants and children are not practical due to their relatively short lifespan 
(approximately 10 years) and their inability to grow with the child.   
  Recently, much work has been put forward into engineering an artificial heart 
valves using biological scaffolds and a patient’s own cells (Dohmen PM, 2009).  If 
successful, this holds the most promise for the future of surgical valvular repair.  Viable 
heart valves, unlike synthetic ones, have the potential to grow, remodel and regenerate, 
thus leading to longer lifespans of the replacement and less complications to the patient 
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(Chambers JC, 1997).   Understanding the specification of cardiac lineages from 
progenitors to differentiated cells to how these cells coordinate their activity to create a 
functional valve leaflet is a crucial first step in the development of viable synthetic heart 
valves.   
 Much work has gone into identifying genes and signaling pathways associated 
with early stages of heart valve development and endothelial-mesenchymal 
transformation (EMT), though later stages of valve development have been more difficult 
to study due to early embryonic lethality in knockouts of critical gene pathways such as 
TGFβ, BMP, Flk and others.  Our laboratory has developed a Cre transgene driven by the 
P2 promoter of NFATc1 which is specific for the pro-valvular endothelial cells of the 
developing heart valve.  This tool will allow us to observe later stages of valve 
remodeling by bypassing the necessity of aforementioned gene pathways in the 
vasculature and other regions of the heart. We chose to examine a role for Tie1 in the 
developing valve leaflet based on its expression pattern during later stages of valve 
development and the evidence for Tie1 function elsewhere in the developing endocardial 
endothelium (Puri MC et al., 1995; Sato TN et al., 1995).  Using the P2Cre, in 
conjunction with a floxed Tie1 allele that has been generated in our laboratory, we 
hypothesize that Tie1 plays a role in late-gestational valve remodeling that was until now 
unable to be studied using the original knockout animals.   
The focus of this research has been to identify a role for Tie1 during valve 
development using an in vivo mouse model in which Tie1 is efficiently deleted in the 
valve endocardium and is normally expressed elsewhere in the mouse. Chapter I will 
describe heart development and outline stages of valve initiation, EMT and remodeling.  
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It will go on to discuss the Tie family of RTKs and their contribution in heart and 
vascular development as well as their role in endothelial cell survival and quiescence.  
Chapter II will outline the spatial-temporal patterns of both Tie1 and the P2Cre in the 
developing mouse and provide insight into the origin of adult valvular endothelial cells.   
Chapter III will detail our experimental model and outline the phenotype of the P2cre 
Tie1flox/lz mouse.  Finally, Chapter IV will conclude by discussing potential Tie1 
signaling mechanisms and highlight future experiments to further determine Tie1’s role 
in the developing valve leaflet.  
 
Heart Development 
 In vertebrate embryos, the heart is the first organ to function and is essential for 
circulation of oxygen and nutrients throughout the body.  Early heart defects commonly 
lead to embryonic demise and it is thought that up to 30% of embryos/fetuses lost prior to 
birth likely had some type of cardiac malformation (Bruneau, 2008). Cardiac 
development in the mouse begins at embryonic day 7.5 (E7.5) in the splanchnic layer of 
the anterior lateral plate mesoderm between the ectoderm and the anterior visceral 
endoderm (Fig. 1.1a, b).  This collection of cells takes on a crescent shape that is well 
conserved across species and is collectively referred to as the cardiac crescent (Harvey, 
2002; Sirvastava, 2006).  Heart progenitors move ventrally to form a linear heart tube, 
which is characterized by an endothelial cell lining and an overlying myocardial 
epithelium.  This linear tube serves as the structural basis for subsequent cardiac 
morphogenesis (Fig 1.1c).  Around E9.5, the linear heart tube begins a complex process 
termed cardiac looping in which the chambers become defined and the atria and outflow 
 4 
tract are positioned above the ventricle.  Swellings within the outflow tract and 
atrioventricular canal (AVC) mark the position of the developing valves and aid in 
unidirectional blood flow through the embryo.  By E10.5, activated endocardial cells 
invade these swellings of the cardiac jelly to become valvular interstitial cells (VICs) that 
populate the valve leaflet (Barnett JV, 2003; Armstrong EJ, 2004) (Fig 1.1e, f). Through 
a distinct process of differentiation, proliferation, apoptosis and ECM remodeling, 
endocardial cushions transform from regional swellings into thin valve leaflets of 
endothelial cells overlying VICs and an intricate matrix of elastin, collagen, 
proteoglycans and glycosoaminoglycans (GAGs) (Schroeder JA et al., 2003).  Cardiac 
looping is completed by E12.5 (Fig 1.1g, h) and from this point the heart undergoes 
remodeling.  The remodeling process persists not until birth, but well into the juvenile 
period.  Trabeculae form along the inner surface of the ventricles, the four chambers are 
divided via septation, and the heart grows along with the embryo at a rapid pace.  
The endocardium, myocardium and extra-cardiac lineage cells are not the only 
players critical for normal heart development.  The Proepicardium (PE) and cardiac 
neural crest cells are also key to formation of a functional heart.  The PE originates at the 
septum transversum and migrates as a sheet over the myocardium at around E10.5 to 
contribute to the epicardium (Mikawa T, 1996).  These epicardial cells then undergo 
EMT and delaminate into myocardium where they then form myofibroblasts, smooth 
muscle cells and endothelial cells.  Cardiac neural crest cells migrate down from the 
hindbrain and contribute to the outflow tract, developing semilunar valves, and 
parasympathetic innervations of the heart.  These neural crest cells are also responsible 
for populating pharyngeal arches 3, 4 and 6 and remodeling these into the aortic arch and 
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Figure 1.1  Developmental events in cardiac formation.  Depiction of the initial 
formation and remodeling of the murine heart.  Adapted from Harvey (2002). 
 
Cranial, Cr; caudal, Ca; endocardial cushion, EC; atrioventricular, AV; right atria, RA; 
right ventricle, RV; left ventricle, LV; left atria, LA; trabeculae, T. 
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its branches (Waldo K, 1999).  In addition, contributions to the outflow tract aid in 
septation of the pulmonary and aortic arteries and generate myocardium and smooth 
muscle in this region (Brown CB, 2006; Red-Horse K, 2010).  
 
Primary and secondary heart fields 
 Construction of the heart is a complex process which involves the integration of 
different cell populations at distinct sites at precise points during the developmental  
process.  Two waves of cell migrations are responsible for bringing heart progenitors to 
the ventral midline where the heart tube will later form.  The first wave is associated with 
gastrulation and is responsible for moving head and heart mesoderm from the node to the 
cranial region of the embryo where the cardiac crescent then forms (P.P. Tam, 1997).   
This migration event is regulated by Fgf8, as well as transcription factors Mesp1 and 
Mesp2 (Sun X, 1999; Kitajima S, 2000).  The second wave of migration moves cardiac 
progenitor cells ventrally to form the heart tube (DeHaan, 1963) and relies on an 
established fibronectin gradient for this movement.  Disruptions in fibronectin lead to a 
complete or partial failure of the cardiac primordial to fuse leading to a condition known 
as cardiac bifida (George EL, 1997).   
 During these migrations, heart progenitors cluster in two distinct fields (Fig 1.2), 
the primary heart field and the secondary heart field.  The secondary heart field is 
positioned dorsally and cranially to the primary heart field.  The primary heart field 
contributes mainly to the left ventricle myocardium as well as parts of the left and right 
atria.  It was previously thought that the endocardium that populates the inner portion of 
the heart tube originates from the primary heart field (Kirby, 2007).  However, more  
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Figure 1. 2  Contributions of the primary heart field, secondary heart field and cardiac 
neural crest to the developing heart.  The first heart field (FHF) (red) contributes to the 
left ventricle (lv) and parts of the left and right atria (la, ra).  The secondary heart field 
(SHF) (yellow)also contributed to the atria as well as the right ventricle (rv), aorta (ao) 
and pulmonary artery (pa).  Cardiac neural crest (blue) populate regions of the outflow 
tract and developing valves.  Adapted from Sirvastava (2006). 
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recent work looking at Nfatc1 as a marker for endocardial endothelium indicate that these 
cells originate from the secondary heart field (Misfeldt AM, 2009).  In addition, the 
secondary heart field contributes to the myocardium of the right ventricle, pharyngeal 
arches, and most notably, the outflow tract (Kirby, 2007) (Fig 1.2).    
Heart Valve Development 
 During development of the heart, the linear heart tube consists of an outer layer of  
myocardium and an inner layer of endocardium that is separated by an acellular layer of 
ECM commonly referred to as the cardiac jelly (Fig 1.3).  By E9.5, swellings of the 
cardiac jelly can be seen in the outflow tract as well as in the atrio-ventricular canal.  
Endothelial cells lining these swellings become activated, downregulate endothelial 
markers such as Pecam-1, and VE-cadherin and activate mesenchymal markers such as 
Snail1 and Twist.  These cells then migrate into the cardiac jelly in a process known as 
endothelial-mesenchymal transformation (EMT) to form the primordial for both the septa 
and the valves.  BMPs and TGF-βs are the inductive signals for the onset of EMT, though 
endocardial Notch signaling must be activated in order for those cells to respond to those 
signals (Timmerman LA, 2004).  It is known that cellular movements during EMT are 
regulated in part by ECM secretions, though this process is poorly understood.  All 
mesenchymal cells of the mitral and tricuspid valves, as well as the proximal cells of the 
semilunar valves are derived from endocardial cells that underwent EMT (Kisanuki YY, 
2001).   
 Disruptions or complete failure to undergo EMT can result in a myriad of 
developmental valve defects.  Inactivation of Has-2, versican, BMPs, Nfatc1 and many 
others results in a complete absence of valve formation (Yamamura, 1997; Ranger AM et 
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al., 1998; Camenisch TD, 2000), whereas mutations in HB-EGF (Jackson LF et al., 
2003), Smad-6 (Galvin KM, 2000) and Neurofibromin1 (Brannan CI, 1994) result in 
hyperproliferative valve leaflets and subsequent hyperplastic valves.   
 While mechanisms regulating EMT are well understood, post-EMT 
differentiation and remodeling of the cushions into thin, mature valve leaflets (Fig 1.3) 
with organized and stratified matrix components has been largely under studied.  It is 
thought that following EMT, a wave of proliferation and apoptosis on the ventricular and 
arterial side of the semilunar valves, respectively, carve out the valve cups  (Fig 1.3) and 
provide the location where the coronary vessels later invade.  Following this stage, the 
valves begin remodeling from regional swellings into thin leaflets.  The ductus arteriosis 
closes around birth which causes a dramatic increase in hemodynamic pressure across the 
aorta.  The heart and valves themselves undergo a rapid growth period after birth. In 
humans, the heart triples in size in the first year of life and continues to grow and remodel 
for several years.  Previously mentioned efforts to surgically replace defective valve 
leaflets in infants and children have been minimally successful due to this rapid growth 
and expansion of the heart and valve tissue.  Synthetic valve replacements must be of a 
precise size to function properly in vivo and any amount of growth in the patient can lead 
to cardiac regurgitation or outright failure of the implant. 
As noted, mutations in many of the genes involved in early cardiovascular 
development are lethal prior to this stage of valve remodeling.  FGF and TGF-β are 
involved in post-EMT valve remodeling by promoting VIC proliferation (Zhao Z, 2000; 
Goumans MJ, 2002).  VEGF is also proposed to be involved in valve remodeling by 
inducing endocardial proliferation through NFATc1 (Dor Y, 2001). 
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Figure 1.3 Schematic of heart valve development.  The three stages of valve 
development leading up to the mature heart valve; initiation, cusp formation and growth 
and remodeling and the corresponding developmental day in mouse and human.   
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Figure 1.4.  (A) Semilunar valves during systole (left) and diastole (right).  (B) Mature 
valve leaflets segregate into trilaminar structures.  The ventricularis (v) is the caudal-most 
region which contains high amounts of elastin.  The spongiosa (s) layer lies in the middle 
and is composed of proteoglycans and glycosoaminoglycans.  The fib (f) layer lies atop 
the spongiosa and contains largely collagens (yellow).  Adapted from Schoen 2008. 
 
 
 
 
 
 
 
 
 12 
The ECM is set up during EMT and plays a critical role in later stages of valve 
remodeling.  ECM provides support for mechanical function, promotes endothelial cell 
invasion into the mesenchyme, and serves as a scaffold for cell migrations (Camenisch 
TD, 2000; Schroeder JA et al., 2003).  During EMT, the main component of the matrix is 
hyaluronan.  During valve remodeling, however, the matrix becomes stratified into a 
trilaminar structure composed mainly of collagen, elastin and proteoglycans (Fig 1.4 b).  
This trilaminar stratification is essential for normal mechanical properties and function of 
the valve leaflets. Elastin fibers in the ventricularis, the caudal most region of the 
semilunar valve, provide support and elasticity to the valve to extend during systole and 
to recoil when the valve closes in diastole (Schoen, 2008) (Fig 1.4 a).  The spongiosa 
layer of the valve sits above the ventricularis and is composed of proteoglycans and 
glycosoaminoglycans. This layer absorbs the contractile forces of the leaflets and 
coordinates movements between the ventricularis and the overlying fib layer (Schoen, 
2008).  Collagen is the major structural component of the fib layer (Fig 1.4 b).  Collagens 
type I, III and V provide the majority of stiffness and strength to the leaflet (W G Cole, 
1984).  Early in development, proteoglycans and glycosoaminoglycans compose the 
majority of the ECM in the valve leaflet.  During remodeling and throughout adulthood, 
collagen becomes more abundant while proteoglycan and glycosoaminoglycan content 
decreases (Aikawa et al., 2006; Chakraborty S, 2008; Peacock JD, 2008).   
 
 Altered expression and distribution patterns of valvular ECM proteins are not 
surprisingly associated with developmental valve abnormalities.  Periostin knockouts, for 
example, lead to truncated heart valves, ectopic cardiomyocytes and smooth muscle cells, 
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perinatal lethality, and disorganized ECM stratification resulting in functional 
deficiencies (Norris RA, 2008).  A total loss of elastin in the mouse embryo results in 
embryonic death approximately mid-gestation, but heterozygous mutants survive long 
enough to display aortic valve insufficiency (Li DY, 1998).  Mutations in fibrilin-1 are 
associated with Marfan syndrome in humans, which leads to aortic valve abnormalities.  
Likewise, mice lacking the associated protein fibulin-4 also exhibit aortic valve 
anomalies including thickened valves and aortic calcification (Dietz HC, 1991; Hanada 
K, 2007).  In addition, mutations in numerous collagens including collagen 1, 2, 3, 5 and 
11 all correlate with various human disorders.  Deletions of these genes in the mouse all 
result in embryonic lethality and display varied cardiovascular abnormalities including 
aortic valve insufficiency (Kuivaniemi H, 1997; Lincoln J, 2006). 
 
The Origin of Valvular Endothelial and Interstitial Cells 
 While much work has been done examining cardiomyocyte specification and 
differentiation, much less is known regarding the origin of the endothelial cells that line 
the inside of the developing heart and valve structures.  The endocardial endothelium is 
known to arise from mesodermal precursors early in development, but markers to 
distinguish endocardium from other endothelium have, until recently, been lacking 
(Misfeldt AM, 2009).  Our laboratory has identified NFATc1 as the only gene expressed 
in early endocardial cells and not other vascular populations (Zhou B et al., 2005).  
Chapter II will discuss NFATc1 in more detail. 
 In the adult animal, much controversy exists over the origin of VICs and the 
overlying endothelial cells.  Several studies have provided evidence that VICs are 
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replaced by circulating endothelial or mesenchymal precursors derived from the bone 
marrow.  Visconti et al. inserted a green fluorescent marker driven by a ubiquitous 
promoter into hematopoietic stem cells and implanted them into lethally irradiated mice.  
Upon dissection, it was found that green fluorescent cells were present in the valve 
interstitium and analysis of those cells demonstrated a function similar to that of VICs 
(Visconti RP, 2006).  What is interesting to note is that no study has provided direct 
evidence of circulating hematopoietic progenitor cells contributing to the endothelial 
lining of the valve leaflets.  Using NFATc1 as a marker of the valve endocardium, we 
will address the lineage of valvular endothelial cells in Chapter II. 
 
The Tie Family of Receptor Tyrosine Kinases 
 The Tie family of receptor tyrosine kinases (RTKs) were first described in 1992 
(Partanen J et al., 1992) and is comprised of two members; Tie1 and Tie2. Tie1 and Tie1 
are selectively localized to endothelial cells and cells of the hematopoietic lineage 
(Dumont DJ et al., 1992; Partanen J et al., 1992; Shahrara S, 2002; Puri MC, 2003).  Tie1 
and Tie2 share a high degree of structural and sequence homology, though the 
angiopoietin (Ang) ligands have been found to associate with Tie2 and not Tie1.  Genetic 
deletions of both Tie1 and Tie2 in the mouse have identified roles in early cardiovascular 
development (Puri MC et al., 1995; Sato TN et al., 1995; Puri MC et al., 1999).  While 
Ang 1-4 have been shown to regulate Tie2 signaling, Tie1 signaling mechanism, ligands 
and downstream targets remain unknown.   
 Deletions of Tie1 in the embryo result in severe edema, hemorrhage, a breakdown 
of the microvasculature and ultimate demise after E14.5 (Puri MC et al., 1995; Sato TN 
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et al., 1995; Qu X, 2010) (Fig. 1.5).  Tie1-/- embryos develop a normal vascular plexus, 
suggesting that Tie1 is not essential in setting up the vascular network.  After E13.5, 
however, the integrity of the vascular plexus is lost, indicating that Tie1 is essential for 
maintenance, survival and quiescence of the endothelium (Puri MC et al., 1995; Sato TN 
et al., 1995; Qu X, 2010).  Tie2 knockout mice die around E10.5 due to a lack of vascular 
remodeling, absent endothelial cell tight junctions, and an overall lack of vascular 
integrity (Dumont DJ et al., 1992).  Double knockouts of both Tie1 and Tie2 are also 
embryonic lethal early in development due to severe cardiovascular abnormalities.  In 
addition, endothelial cells lacking both Tie1 and Tie2 do not contribute to the mature 
vasculature (Puri MC et al., 1999). 
 Tie1 expression in the mouse embryo is turned on around E8.5 following 
activation of Flk-1, Flt-1 and Tie2, thus being the last RTK to be activated during 
vascular development.  In the early embryo, Tie1 expression can be visualized in the yolk 
sac and developing vascular plexus.  By E12.5, Tie1 is robustly expressed in the lung, 
vasculature, heart, liver, brain and kidneys.  In the adult animal, low levels of expression 
remain in the heart and branch points of the aorta (Woo KV, 2011), although expression 
is lost in other organs. 
 The Tie1 and Tie2 receptors have remarkably similar structure. The extracellular 
region of each receptor has two immunoglobulin (Ig) domains, followed by three EGF 
repeats, an additional Ig domain, and three fibronectin type III repeats. The intracellular 
portion contains the kinase domain (Partanen J et al., 1992; Macdonald PR, 2006) (Fig 
1.6).  The sequence homology of the intracellular domain is quite high, approximately 
80%, however the extracellular domain is much more diverse.  The highest amino acid 
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conservation is in the EFG repeats (50-55%), an area essential for Ang ligand binding 
(Fig 1.6 a).  The homology rates in the EGF repeat region may explain why Ang 1-4 are 
selective for Tie2 but not Tie1 (Macdonald PR, 2006). 
Endothelial Specific Receptor Tyrosine Kinases in Valve Development 
 Tie1 and Tie2 are not the only endothelial specific RTKs expressed during 
cardiovascular development.  NFAT has been shown to be a negative regulator of VEGF, 
thus promoting the onset of EMT in valve development and Flk-1 (VEGFR-2) has been 
shown to induce translocation of NFATc1 to the nucleus (Johnson EN, 2003). Flk-1 null 
mice lack mature endothelial cells and die around E8.5-9.5 (Shalaby F, 1995).  A lack of 
endothelial cells limits EMT, which would lead to subsequent valvular defects should 
these embryos live past E9.5.  Flt-1  (VEGFR-1) is highly expressed in the endocardial 
endothelium prior to EMT and subsides following EMT initiation.  While Flt-1 mice do 
possess mature endothelial cells, blood vessels are poorly organized therefore ultimately 
leading to embryonic demise at E8 (Fong GH, 1995).  
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Figure 1.5.  Loss of Tie1 leads to early embryonic lethality.  Deletion of Tie1 leads to a 
loss of vascular integrity in the mouse embryo resulting in edema and embryonic death 
by E16.5 (A-G).  (H)  Insertion of a neomycin cassette into the Tie1 locus significantly 
reduces Tie1 expression.  Figure adapted from Qu et al 2010.   
 
 
 
 
 18 
 
 
 
 
 
 
 
Figure 1.6.  Tie1 and Tie2 receptor structure.  (A) Early model of Tie1 and Tie2 
receptor structure with domain homology comparisons.  (B) Latest model of Tie1 and 
Tie2 receptor structure.  Note the recent identification of a third Ig-like domain.  These 
receptors can homo-  or heterodimerize with each other at the intracellular kinase domain.  
Interactions between the extracellular regions has not been reported.  Adapted from Sato 
et al (1993) and Macdonald et al (2006).   
 
Immunoglobulin-like, Ig; epidermal growth factor, EGF; Angiopoietin, Ang; 
Transmembrane, TM; Fibronectin Type III, FNIII; Tyrosine kinase, TK. 
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Mechanisms of Tie1 Signaling 
 Although there is a high degree of structural and sequence homology between 
Tie1 and Tie2, a ligand for Tie1 has yet to be identified.  This has made efforts to 
elucidate the signaling mechanisms of Tie1 quite difficult.   
 Evidence has shown that Ang1 and Ang2 can activate the Tie1 receptor in some 
instances, although no direct receptor-ligand interaction has been identified in vivo (Davis 
S et al., 1996; Maisonpierre PC et al., 1997; Valenzuela DM et al., 1999) (Fig 1.7).  To 
gain insight into Tie1 signaling, two groups utilized a chimeric receptor approach 
(Marron MB et al., 2000a; Kontos CD et al., 2002).  Marron et al. generated a fusion of 
the TrkA receptor tyrosine kinase ectodomain to the intracellular and transmembrane 
domains of Tie1.  Activation of TrkA via NGF signaling did not result in Tie1 
phosphorylation.  While this approach was unsuccessful, the same group identified an 
association between Tie1 and Shp2 (Marron MB et al., 2000b).  Shp2 is a protein 
tyrosine phosphatase that plays a regulatory role in cell signaling, migration and 
transcription regulation.  Mutations in Shp2 have been implicated in Noonan’s 
Syndrome.  Data from this latter paper suggests that the phosphorylated state of Tie1 may 
be transient, therefore not detected in previous studies.   
 A later paper by Kontos et al used a similar approach to examine the signaling 
mechanism and function of Tie1.  This group used a cell line that stably expressed csf-
Tie1 (colony stimulating factor receptor-Tie1 fusion) to show that Tie1 can auto-
phosphorylate in the absence of Tie2 (Kontos CD et al., 2002).  This paper also 
demonstrates that in vitro the Tie1 endodomain can associate with the p85 subunit of  
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Figure 1.7.  Tie1 and Tie2 signaling pathways.  Summary of Tie1 and Tie2 signaling.  
Many more signaling pathways have been identified downstream of Tie2 as compared to 
Tie1, though more recent work has identified SHP-2 and PI3K/AKT as targets of Tie1 
signaling.  Adapted from Loughna and Sato (2001). 
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PI3K subsequently causes phosphorylation of Akt, thereby inhibiting endothelial cell 
apoptosis (Fig. 1.7). 
 
This study was the first to suggest that Tie1 can homodimerize and may 
autophosphorylate, therefore being able to signal in the absence of Tie2.   Taken together, 
Tie1 may play a role in signaling independent of Tie2, even though their signaling 
pathways may overlap.    
 A more recent paper sought to examine the interactions between Tie1 and Tie2 in 
vitro (Kim KL, 2006).  This group studied expression levels of both Tie1 and Tie2 in 
endothelial progenitor cells (EPCs) and in HUVECs and found similar levels of 
expression in each cell type.  Tie1 was found to associate with Tie2 in the mature cell 
type (HUVECs) but not in EPCs, suggesting that Tie1s role in development is context-
dependent.  In addition, Tie1-Tie2 heterocomplexes inhibit Ang2 from binding to and 
activating Tie2 signaling in HUVECs.  More work needs to be done in this area to 
determine if similar events take place in vivo.  
 Tie1 is not only functional during development.  Recent studies have implicated a 
role for Tie1 in inflammatory diseases such as rheumatoid arthritis, osteoarthritis and 
atherosclerosis (Shahrara S, 2002; Porat RM, 2004; Woo KV, 2011).  Tie2 activation via 
Ang1 promotes endothelial cell survival and integrity (Kwak HJ, 2000; Papapetropoulos 
A, 2000), therefore Tie1 may be able to activate endothelial cells by inhibition of Ang1-
mediated Tie2 activation. The overexpression of Tie1 in HUVECs increases expression 
of the inflammatory markers VCAM-1, ICAM-1 and E-selectin (Aikawa et al., 2006; 
Chan B, 2008).  Likewise, a reduction of Tie1 expression in HUVECs results in a 
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decrease in TLR2, IL-1β, VCAM-1, ICAM-1 and E-selectin, though Tie2, eNOS and 
TGF-β were unperturbed (Chan B, 2009).  Taken together, these data suggest that Tie1 
may play a role in promoting inflammation as well as endothelial cell activation during 
development and disease.  
 In summary, the Tie family of RTKs is essential for the maintenance of 
endothelial and vascular integrity in the developing embryo.  Global knockouts of either 
receptor result in embryonic lethality, and double knockouts compound this phenotype 
suggesting that interactions exist between Tie1 and Tie2, and that these interactions may 
be context dependant.  Although Tie1 and Tie2 share much homology in the intracellular 
region, their extracellular regions are quite different from each other.  Since the 
extracellular region is critical for ligand binding, the lower homology rates between Tie1 
and Tie2 is likely why the Ang ligands have been found to interact with Tie2 but not 
Tie1.  With the exception of the original knockout papers and a few recent manuscripts, 
the majority of the information on Tie1 has been ascertained from in vitro experiments.  
To effectively determine a role for Tie1 we must be able to make conclusions on what 
actually happens in an in vivo model.   
 
Aims of this Dissertation 
 Global knockouts of Tie1 result in embryonic demise due to a breakdown in the 
integrity of the microvasculature.  Because of the high expression levels of Tie1 in the 
valve, we hypothesize that Tie1 may have a role in valve development that was 
previously undetermined due to the vascular phenotype and early demise.  To test this 
hypothesis we propose to: 
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Aim 1.    Define the expression pattern of Tie1 in the developing valve leaflet and 
determine the spatio-temporal pattern of the valvular endothelial specific NFATc1-
P2Cre.  To this point, evaluation of endothelial specific genes in late stages of valve 
remodeling has been unattainable due to the requirement of these genes in the 
vasculature.  The NFATc1-P2Cre is specific for the developing pro-valve endocardium, 
and provides a tool to bypass the requirement of essential genes in vascular development. 
Tie1 promoter-LacZ reporter mice were dissected and stained with X-gal to determine the 
expression pattern of Tie1 in the developing valve leaflets.  Likewise, we examined the 
spatio-temporal patterning of the NFAT-c1 P2Cre using a  R26R reporter and real time 
PCR.  We have determined that endothelial cells of the embryonic valve leaflet go on to 
contribute to the endothelium of the mature adult valve. 
Aim 2.  Define the effect of Tie1 deletion in the developing valve endocardium.  Using a 
conditional Tie1 floxed allele, the Tie1 LacZ knockin, and the NFATc1-P2Cre, we will 
generate mice that are deficient for Tie1 in the valve endocardium (P2Cre Tie1flox/lz).  
Semilunar and atrio-ventricular valves of these animals will be compared to Tie1flox/flox 
littermates that are equivalent to wild-type animals.  We have determined that P2Cre 
Tie1flox/lz aortic valves are significantly larger than Tie1flox/flox valves.   
Aim 3.  Determine if interactions between Tie1 and Tie2 exist in the developing valve 
leaflet.  The signaling mechanisms and downstream targets of Tie1 are mostly unknown, 
and no information on Tie1 signaling in vivo has been determined. To elucidate Tie1 
signaling mechanisms, we have isolate valve leaflets from P0 P2Cre Tie1flox/lz and 
Tie1flox/flox animals and use Western blotting to determine if a loss of Tie1 has any effect 
on the phosphorylation of Tie2 in this context.  We will also construct a Tie2 floxed allele 
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to determine potential genetic interactions between Tie1 and Tie2 in the developing 
valve.  RT-PCR and RNA sequencing will be used to determine the downstream 
signaling targets of Tie1.  
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CHAPTER II 
 
 
 
SPATIAL AND TEMPORAL PATTERNING OF TIE1 AND NFATc1 P2CRE  
DURING HEART DEVELOPMENT 
 
 
 
Introduction 
 
 Animal models to assess gene function during late gestational heart development 
have been largely unavailable since most gene knockouts that affect heart development 
result in embryonic lethality before valve remodeling takes place.  Our laboratory has 
developed a Cre transgenic line using the P2 promoter of NFATc1 that is specific for the 
pro-valve endocardium (Zhou B et al., 2005).  In conjunction with a conditional floxed 
allele, we are able to bypass the requirement for essential genes in the developing embryo 
to examine their function specifically in the endothelial cells lining the valve.  In 
addition, the Cre marks a specific subset of valvular endothelial cells that do not 
transform into mesenchyme, therefore lineage tracing via R26R does not yield any Cre 
positive cells in the valve interstitium.   
 The Nuclear Factor of Activated T-cells (NFAT) family of transcription factors 
consists of five members:  NFATc1, NFATc2, NFATc3, NFATc4 and NFATc5.  NFAT 
is found not only in T-cells but in various other tissues including the developing heart 
(Rao A, 1997; Crabtree GR, 2002; Hogan PG, 2003; Macian, 2005).  The structure of the 
NFAT family members is highly conserved (Fig 2.1 a).  Each has an NFAT homology 
domain (NHR), which has numerous serine residues to regulate activity via 
phosphorylation and a transactivation domain with binding sites for calcineurin, NFAT 
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kinases and GSK3β.  Each NFAT family member also has a REL homology region 
(RHR), which consists of a DNA binding domain with homology to the REL family of 
transcription factors (also known as the NF-κB family of transcription factors).  Calcium 
signaling regulates the transcriptional activity of NFATc1-4 (Fig 2.1 b).  When calcium 
waves are released, formation of calmodulin and calcineurin phosphatase complexes are 
induced that in turn dephosphorylate NFATc.  NFATc then translocates into the nucleus 
where it activates transcription of downstream targets.   
 During heart development, NFATc1 is expressed in endocardial precursors in the 
linear heart tube. By E10.5, expression is restricted to the endocardium of the AVC and 
OFT valves.  NFATc1 is no longer expressed in the heart after E12.5.  Deletions of either 
the RHR or NHR result in an absence of valve leaflets.  Promoter analysis of NFATc1 in 
our laboratory identified a 250bp region just upstream of the P2 promoter element that 
was responsible for autoregulation of NFATc1 (Zhou B et al., 2005).  This element was 
able to drive lacZ reporter gene expression in the pro-valve endocardium at E9.5 through 
E13.5.  No reporter gene expression was noted in other regions of the endocardium.  
Therefore, this region was selected to develop a highly region specific and tissue specific 
mouse line; the NFATc1 P2 Cre.   
 Tie1 has been shown to be expressed throughout the endothelium of the 
developing embryo after E9.5 (Partanen J et al., 1992).  However, a full detailed timeline 
of expression in the heart has not yet been described. Tie1 expression is high in the 
embryo prior to E14.5 then is reduced in most regions of the heart and vasculature.  We 
show that Tie1 is expressed specifically on the arterial side of the semilunar valve leaflet 
in the adult, as well as branch points along the aorta where turbulent flow is present.  
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Figure 2.1.  Structure and signaling of NFAT transcription factors.  NFAT family 
members (a).  Adapted from Macian et al 2005.  When intracellular calcium increases, 
(b) the calcium-calmodulin-calcineurin complex dephosphorylates NFAT.  This leads to 
nuclear localization and activation of downstream transcriptional regulation. Adapted 
from Steinbach et al 2007. 
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Regions of the heart and vasculature under laminar sheer stress express little to no Tie1 in 
the adult mouse. 
 
Experimental Procedures 
 
Genotyping 
 Tail samples were obtained from three week old mice and digested in a buffer 
containing 100 mM Tris pH 8.5, 5 mM EDTA, 0.2% sodium dodecyl sulfate (SDS), 200 
mM NaCl and 100 µg/ml Proteinase K overnight at 55°C.  Tail DNA was then genotyped 
by PCR using Taq polymerase (Roche) or REDExtract-N-Amp PCR Reaction Mix 
(Sigma) using the following primers: 
Tie1-lz:  5’ – TGC CCC CCC TTC CAG AGA CTT CC – 3’, 5’ – GCA AAG AGG ATC 
CCC ACC AGA CCA TACT -3’ and 5’ – GGG GAT GTG CTG CAA GGC GAT TAA 
G – 3’ 
Cre:  5’ - TCC GGG CTG CCA CGA CCA A -3’ and 5’ – GGC GCG GCA ACA CCA 
TTT TT -3’ 
 R26R:  5’ – GCG AAG AGT TTG TCC TCA ACC -3’, 5’ - GGA GCG GGA GAA 
ATG GAT ATG – 3’ and 5’ – AAA GTC GCT CTG AGT TGT TAT -3’ 
 
Animal Breeding 
 Tie1 lz/+ mice (a kind gift from Dr. Mira Puri, University of Toronto) were bred 
to WT ICR mice in our animal facility.  Likewise, R26R mice were backcrossed to each 
other to maintain homozygosity.  All animals were maintained in microisolator cages and 
 29 
were fed normal rodent chow (Purina Mills).  All experimental procedures were 
performed according to Vanderbilt University’s Institutional Animal Care and Use 
Committee.   
 
Detection of β-galactosidase 
 Tissue was collected in PBS and fixed overnight at 4°C in 4% PFA/PBS.  Fixed 
tissue was then washed in a solution containing 2 mM MgCl, 5 mM EGTA, 0.01% 
deoxycholate, 0.02% NP-40, and 0.1 M phosphate buffer.  The tissue was then stained in 
1 mg/ml X-gal, 5 mM potassium ferro/ferricyanate, 2 mM MgCl, 0.01% deoxycholate, 
0.02% NP-40, overnight at 30°C.  Stained tissue was then post fixed in 4% PFA/PBS for 
up to eight hours, washed and cleared in a glycerol gradient and photographed with a 
dissection photomicroscope.  Once photographed, samples were again washed, 
dehydrated in a graded ethanol series, and embedded in paraffin.  Paraffin blocks were 
sectioned at 6-7µm on a microtome.  Slides were counterstained with Eosin and mounted 
with Permount. 
qRT-PCR 
 All qRT-PCR was performed using iQ SYBR Green Supermix (Bio-Rad) on the 
iQ5 Real Time PCR Detection System (BioRad).  Assays were performed in triplicate 
using glyceraldehyde-3-phosphatase dehydrogenase (GAPDH) as the normalization 
control.  Relative expression was calculated as Δ2-ct (Schmittgen, 2008).  Primers used are 
as follows: 
GAPDH:  5’ – CAC TGG CAT GGC CTT CCG TG -3’and 5’- AGG AAA TGA GCT 
TGA CAA AG -3’ 
 30 
Cre:  5’- TGC AAC GAG TGA TGA GGT TC -3’and 5’ –GCA AAC GGA CAG AAG 
CAT TT -3’ 
 Heart tissues from E9.5, E12.5 and E14.5 were collected from P2Cre mice and 
yolk sacs were collected as control tissue.  The cranial half of the P0 heart was collected 
and in the absence of P0 yolk sacs, the lung was collected as the negative control.  RNA 
was isolated with a standard Trizol preparation (Invitrogen). For statistical purposes, E9.5 
yolk sac was set to a value of 1 and all fold changes shown are set relative to that value. 
 
Results 
Tie1 Expression is Localized to the Endothelium of the Developing Embryo 
 At E8.5, Tie1 is the last RTK to be turned on during vascular development.  Tie1 
is localized to the developing endothelium and can be seen early in the developing yolk 
sac vasculature and the great vessels of the embryo.  By E9.5, Tie1 is robustly expressed 
in all the embryonic vasculature (Fig 2.2 A).  By E12.5, Tie1 expression is also seen in 
the developing lung, brain and heart, including the endothelium of the ventricles, atria, 
and valve leaflets (Fig 2.2 B).  High levels of Tie1 expression persist through the 
postnatal period then begin to taper off in older animals.  In the adult mouse, Tie1 
expression is localized to regions of the cardiovascular system with high levels of 
turbulent flow in areas of resistance.  These regions include the arterial side of the 
semilunar valves and branch points of the aorta.  Laminar flow has been shown to 
downregulate Tie1 expression (Chen-Konak L, 2003), which explains why Tie1 is not 
expressed on the ventricular side of the valve leaflets nor in straight regions of the aorta. 
 
 31 
 
 
A 
 
 
B 
 
 
 
Figure 2.2.  Tie1 expression throughout development.  (A) Tie1 is expressed throughout 
the embryonic endothelium at E9.5 including the umbilical vein (arrow) and the yolk sac.  
Adapted from Uyttendaele et al 2001. (B) Using the Tie1 LacZ (Tie1 lz) knockin (Dr. 
Mira Puri), we are able to visualize Tie1 expression throughout the developing heart and 
valve leaflets.  Tie1 is first expressed around E8.5 in the developing vasculature.  By 
E12.5, high expression levels are seen in the lung, brain and cardiovascular system. 
Expression after P0 diminishes, but are seen on the arterial side of the valve leaflets and 
branch points of the aorta in the adult. 
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Spatio-temporal patterning of the NFATc1 P2Cre  
  When the P2Cre transgenic line was first generated, it was communicated that the 
Cre was only expressed for a short window during development; sometime between E9.0 
and E12.5.  There was no definitive evidence, however, to support this timeline.  Here we 
are the first to document the timeline of the P2Cre.  Quantitative Real Time PCR data 
shows that the P2Cre is expressed by E9.5 in isolated heart tissue.  Expression continues 
through E12.5 and E14.5 when it is then turned off (Fig 2.4).  No Cre expression is noted 
after E14.5.  As expected, no Cre expression was noted in yolk sac or lung at any stage 
examined.   
 We crossed P2Cre animals with R26R reporter mice to determine the spatial 
patterning of the P2Cre.  R26R stains robustly in the pro-valve endocardium at E12.5 
(Fig. 2.3) but can be seen as early as E9.0 in the common AVC and OFT.  The R26R 
reporter also labels valve endocardial cells in P0 and adult animals.  This result was 
unexpected even though we have shown that the Cre is not being expressed at these later 
time points.  This indicates that the cells of the adult valve endocardium originated from 
early embryonic endocardial cells and are not replaced by circulating endothelial 
progenitor cells or other methods as previously thought. 
 
Discussion 
 Few in vivo studies have focused on Tie1 other than the original knockout papers 
(Puri MC et al., 1995; Sato TN et al., 1995), in part because no ligand has been identified 
for Tie1 but also the early lethality makes studying later developmental events 
impossible.  Using the P2Cre, we now have a tool to study the effects of conditionally  
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Figure 2.3.   P2Cre R26R expression.  The P2Cre is active from E8.5 through E14.5 in 
the pro-valve endocardium.  Expression of the Cre is restricted to the endothelium of the 
developing valves (arrowhead) and not the endothelium of the OFT (arrow).  After the 
Cre is turned off, R26R expression remains in the majority of the valvular endothelial 
cells through adulthood. 
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Figure 2. 4 P2Cre qRT-PCR.  P2Cre expression was measured by quantitative Real 
Time PCR.  Expression levels were normalized to E9.5 yolk sac.   
 
Yolk sac, Ys; heart, H; lung, Lg. 
 
 
 
 
 
 
 
0.0 5.0 
10.0 15.0 
20.0 25.0 
E9.5 Ys  E9.5 H  E12.5 Ys  E12.5 H  E14.5 Ys  E14.5 H  P0 Lg  P0 H 
P2Cre qRT‐PCR 
 35 
deleted genes in the developing heart valves.  We can therefore bypass the requirement 
for Tie1 in the developing vasculature and keep these embryos alive so that we can study 
the role of Tie1 in late-gestational valve development and remodeling.   
We first examined the expression pattern of Tie1 throughout embryonic 
development to be certain that Tie1 is expressed in the developing valve leaflet at the 
time that the Cre is active.  Tie1 expression turns on at approximately E8.5, within hours 
of P2Cre activation. We also determined that Tie1 expression in the valve persists into 
adulthood, indicating that it may play a role in maintenance of the valve endothelium.   
 We provide the first definitive timeline for the P2Cre during development.  The 
P2Cre is expressed by E9.0 and remains active until E14.5.  More importantly, using an 
R26R reporter we have shown that cells once expressing Cre (or descendents thereof) 
make up the vast majority of the valve endothelium well into adulthood.  This indicates 
that deletion of Tie1 in between E9.0 and E14.5 likely is sufficient to eliminate all Tie1 
expression in the valve leaflet for the life of the animal, as the valvular endothelial cells 
are not being replaced.  We can conclude from these data that the endothelial cells in the 
valve leaflet at E9.5 are the same cells as those in the P0 animal and the same as those 
cells in the adult mouse.  The cells of the valve endocardium are not replaced by 
circulating EPCs or by cells from any other source.  This settles a long debate of the 
origin of adult valvular endothelial cells in the field of cardiovascular development. 
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CHAPTER III 
 
 
TIE1 IS A REGULATOR OF LATE GESTATIONAL SEMILUNAR VALVE 
REMODELING 
 
 
Introduction 
 
 Chapter II outlined the spatio-temporal pattern of Tie1 expression in the 
developing embryo.  Expression of Tie1 appears in the cardiac cushions by E9.5 and 
persists through the neonatal period.  Adult Tie1 expression is restricted to the arterial 
side of the valve leaflet.  We hypothesize that this localized expression of Tie1 aids in 
valve remodeling by sending information to the VICs and the ECM to properly stratify 
the matrix during late gestational remodeling.  Since Tie1 global knockouts die around 
E14.5, examining a role for Tie1 in later stages of valve development in vivo has been 
impossible.  Thus, the majority of literature on Tie1 comes from in vitro studies.  Tie1 in 
vitro appears to play a role in endothelial cell survival and quiescence (Patan, 1998), 
though these studies examined only cell lines of the vasculature.  It is likely that Tie1 
may play a similar role in developing valve, but it is just as likely that the role for Tie1 is 
context dependant both spatially and temporally.  
 Using a conditional Tie1 floxed allele that was developed in our laboratory (Qu X, 
2010) in conjunction with the Tie1 lz knockin and the P2Cre, we generated mice that lack 
Tie1 in the valve endocardium (further referred to as P2Cre Tie1flox/lz).  These animals 
have aortic valves that are much larger than their wild type littermates. We hypothesize 
that Tie1 does play a critical role in valve development and here we examine in depth the 
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effects of a loss of Tie1 in the valve leaflet and how this loss contributes to structural 
changes and functional abnormalities in the mouse.  
  
Experimental Procedures 
Genotyping 
 Tail samples were obtained from three week old mice and digested in a buffer 
containing 100 mM Tris pH 8.5, 5 mM EDTA, 0.2% sodium dodecyl sulfate (SDS), 200 
mM NaCl and 100 µg/ml Proteinase K overnight at 55°C.  Tail DNA was then genotyped 
by PCR using Taq polymerase (Roche) or REDExtract-N-Amp PCR Reaction Mix 
(Sigma) using the following primers: 
Tie1-lz:  5’ – TGC CCC CCC TTC CAG AGA CTT CC – 3’, 5’ – GCA AAG AGG ATC 
CCC ACC AGA CCA TACT -3’ and 5’ – GGG GAT GTG CTG CAA GGC GAT TAA 
G – 3’ 
Tie1 flox:  5’ – TCG GGC GCG TTC AGA GTG GTA T -3’ and 5’ – ATG CCT GTT 
CTA TTT ATT TTT CCA G -3’ 
Cre:  5’ - TCC GGG CTG CCA CGA CCA A -3’ and 5’ – GGC GCG GCA ACA CCA 
TTT TT -3’ 
 
Generation of Tie1 mutant alleles 
 Tie1flox animals were developed in our laboratory.  A loxP site and a neomycin 
resistance cassette were inserted into the first intron of Tie1, and a second loxP site was 
inserted just upstream of the minimal promoter region.  When introduced to Cre 
recombinase, the Tie1 minimal promoter and exon 1 are excised.   
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Animal Breeding  
 Tie1 flox/flox mice were bred to Tie1 lz/+ (A lacZ knockin to the Tie1 locus resulting 
in one null allele) to generate Tie1flox/lz mice.  These animals were then crossed to P2Cre 
Tie1 flox/flox mice.  Results of this cross generates 25% of each of the following offspring; 
Tie1flox/flox, Tie1flox/lz, P2Cre Tie1 flox/flox and P2Cre Tie1 flox/lz. All animals were 
maintained in microisolator cages and were fed normal rodent chow (Purina Mills).  All 
experimental procedures were performed according to Vanderbilt University’s Animal 
Care and use Committee.   
 
Immunohistochemistry 
 Adult, P0 and prenatal tissue was extracted in PBS and flash frozen in OCT 
(Tissue Tek).  Tissue was sectioned at 7-10µm onto charged slides using a cryostat 
(Leica) and stored at -80°C until ready for use.  The following primary antibodies were 
used to examine the valve phenotype of P2Cre Tie1 flox/lz mice;  
Rat monoclonal CD31 antibody (GeneTex) 1:100  
Mouse monoclonal Chondroitin Sulfate (Abcam) 1:200  
Rabbit polyclonal Fibronectin (Abcam) 1:100; 
Rat monoclonal Heparan Sulfate Proteoglycan 2 (Abcam) 1:200 
Phosphohistone H3 (Cell Signaling) 1:100  
Rabbit polyclonal Smooth muscle actin (Abcam) 1:200 
Rat monoclonal Tenascin C (Abcam) 1:200 
Rabbit polyclonal VE Cadherin (Abcam) 1:50  
 39 
Rabbit polyclonal ZO-1 (Invitrogen) 1:200 
Rabbit monoclonal Periostin (a kind gift from Dr. Stan Hoffman, Medical University of 
South Carolina) 1:200.   
 Sections were fixed with 4% PFA or acetone as required.   Primary antibodies 
were incubated overnight at 4°C and immunodetected with the appropriate secondary 
antibody for 30 minutes at room temperature.  Samples were mounted with Vectashield 
containing DAPI (Vector Labs).  Sections were visualized on a Nikon Elipse E800 
epifluorescence microscope and imaged using SPOT Imaging software.   
 
Laser Capture Microdissection 
 P0 and E14.5 hearts were flash-frozen in OCT (Tissue Tek) and sectioned at 7 µm 
on a cryostat (Leica).  Sections were then washed with water, dehydrated and stained 
briefly with toluene blue for visualization.  Pulmonary and aortic valve tissue were 
immediately collected via laser capture (Leica).   
 
RNA isolation and cDNA preparation 
 RNA from laser-captured tissue was isolated using the PicoPure RNA Isolation 
Kit (Arcturus).  RNA from microdissected tissue was isolated using a standard Trizol 
prep (Invitrogen).  cDNA was obtained using a standard protocol (Invitrogen).   
 
Quantitative real-time PCR (qRT-PCR) 
 All qRT-PCR was performed using iQ SYBR Green Supermix (Bio-Rad) on the 
iQ5 Real Time PCR Detection System (BioRad).  Experiments were performed in 
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triplicate using glyceraldehyde-3-phosphatase dehydrogenase (GAPDH) as the 
housekeeping control to normalize data.  Relative expression was calculated as Δ2-ct 
(Schmittgen, 2008).  Primers used are as follows: 
Tie1:  5’ – GTG CCA CCA TTT TGA CAC TG -3’ and 5’ – CAG GCA CAG CAG GTT 
GTA GA -3’ 
GAPDH:  5’ – CAC TGG CAT GGC CTT CCG TG -3’and 5’- AGG AAA TGA GCT 
TGA CAA AG -3’ 
 
Area Measurements 
H&E stained sections were measured for overall valve area.  3-5 animals per 
genotype per age group were selected and valve area in 5-8 consecutive sections of the 
aortic and pulmonary valves was quantitated.  Areas given represent the mean area of two 
valve leaflets in a field.  Measurements were performed using The Image Processer 
software.  Statistical analysis was performed using a Student’s T-Test in Excel. 
 
Von Kossa Stain for Calcium 
Paraffin sections were deparaffinized and hydrated to water.  Slides were placed 
in 3% silver nitrate and exposed to light for 30 minutes until calcium minerals in the 
tissue absorbed the stain.  Sections were washed in water, placed in sodium thiosulfate 
for two minutes then counterstained with Nuclear Fast Red.  Tissue was then dehydrated 
in a graded ethanol series, cleared in Xylene and mounted with Permount. 
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Hyaluronic Acid Staining 
 Frozen sections were used examine hyaluronic acid content in the adult valve.  
Sections were washed with PBS and fixed for 10 minutes in 4% PFA.  Slides were then 
rinsed with PBS and half the samples were digested with bovine testicular hyaluronidase 
1:20 in 5% PBST for one hour at room temperature.  All slides were then rinsed with 
acetic acid 3% and stained with alcian blue (pH 2.5) for 15 minutes.  Slides were 
counterstained with Nuclear Fast Red for 10 minutes, washed with water, dehydrated 
through a graded ethanol series and mounted with Permount.   
 
Modified Movat’s Pentachrome Stain 
 Paraffin sections of adult valve leaflets were used to study the effects of a loss of 
Tie1 on the ECM.  Sections were deparaffinized in xylene and hydrated through a graded 
ethanol series into water.  Slides were then stained in alcian blue for two hours, washed in 
running water then exposed to alkaline alcohol for one hour to convert alcian blue into 
insoluble monastral fast blue.  Slides were then washed with water and stained in 
Verheoff’s hematoxylin to visualize elastin and nuclei.  A wash in sodium thiosulfate was 
followed by five minutes in crocein scarlet-acid fuchsin to stain fibrin and muscle 
red/pink.  Slides were then differentiated in 5% aqueous phosphotungstic acid, 
dehydrated and stained in Saffron for 15-20 minutes to visualize collagens.  Slides were 
finally washed in 100% ethanol, two changes of xylene, and mounted with Permount.  
The Movat’s Pentachrome kit was purchased from PolyScientific. 
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Echocardiograms 
The mice were sedated with isoflurane then placed on a heated table with 
isoflurane for continued anesthesia.  The mice were restrained and an echocardiogram 
was performed with a VisualSonics Vevo 2100 using the MS-400 probe (18-38 MHz).  2-
dimensional imaging was obtained in the long axis, short axis, apical 4-chamber, and 
aortic arch views; color flow mapping was used to assess for insufficiency of the 
semilunar and atrioventricular valves and Pulsed wave Doppler of the semilunar and 
atrioventricular valves was obtained to evaluate for valvuar stenosis. M-mode 
measurements were performed in short axis to assess ventricular function and chamber 
dimensions. 
 
Atomic Force Microscopy 
The stiffness of the valves was determined by measuring the modulus using a 
Catalyst Bioscope atomic force microscope (AFM) (Bruker AXS, Madison WI, USA). 
Where Ftip is the force on the tip, E is the Young’s modulus, R is the tip radius, d is the 
distance between the sample and tip, and Fadh is the adhesive force between the sample 
and tip. The tips were borosilicate glass beads attached to silicon nitride-coated 
cantilevers with a nominal diameter of 5 mm and nominal spring constant of 0.03 N/m 
(Novascan Technologies, Inc., Ames IA, USA. Tips were calibrated on a PDMS substrate 
of known stiffness prior to sample measurements. Scan parameters were: scan size 
between 25 mm x 25 mm and 30 mm x 30 mm, scan rate 0.1 Hz, and peak force setpoint 
of 1 nN. A total of 3 samples per genotype were used and each sample was scanned three 
times in adjacent areas on the valves.  
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ECM Quantitation 
 Collagen from Tie1flox/flox and P2Cre Tie1flox/lz was measured using the Sircol 
Soluble Collagen Assay (Biocolor Ltd.).  Aortic and pulmonary valves from 4 animals 
were pooled for each sample.  A total of 3 Tie1flox/flox and 3 P2Cre Tie1flox/lz samples 
were measured with a microplate reader.  Glycosoaminoglycans from Tie1flox/flox and 
P2Cre Tie1flox/lz was measured using the Blyscan Sulfated Glycosaminoglycan Assay 
(Biocolor Ltd.) Again, a total of 3 Tie1flox/flox and 3 P2Cre Tie1flox/lz samples (each 
sample contained a pool of leaflets from 4 mice) were used for quantitation. 
 
Results 
Loss of Tie1 in the valve endocardium reduces embryonic survival rates 
As described above, Tie1flox/lz mice were crossed with P2Cre Tie1flox/lz animals to 
generate 25% of each of the following offspring: Tie1flox/lz, Tie1flox/flox, P2Cre Tie1flox/lz 
and P2Cre Tie1flox/flox (Fig 3.1 A).  Deletion of Tie1 in the valve leaflets results in 
reduced survival of P2Cre Tie1flox/lz offspring.  Less than half of P2Cre Tie1flox/lz pups 
survive past weening (Fig. 3.1 A, green bars).  Embryos that die in utero typically exhibit 
edema after E14.5.  The majority of P2Cre Tie1flox/lz pups born are smaller and more 
lethargic than WT littermates, a common phenomenon associated with human patients 
that have heart defects.   
qRT-PCR from laser captured valves shows that we have deleted Tie1 by 
approximately 5-fold in the embryo and P0 pulmonary and aortic valves (Fig 3.1 B).  
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Reduction of Tie1 in the adult was less dramatic, likely due to the diminished 
endogenous expression of Tie1 in the adult valves.   
 
P2Cre Tie1flox/lz mice have larger aortic valves than Tie1flox/flox 
 Since we have deleted Tie1 in the valve endocardium, we sectioned valve leaflets 
at different stages of development to examine their morphology.  We noted that after 
E14.5 P2Cre Tie1flox/lz aortic valves were larger than Tie1 flox/flox valves (Figure 3.2 A).  
We quantitated this and discovered that indeed, P2Cre Tie1flox/lz aortic valves are larger 
than that of their littermates (Fig 3.2 B).  Adult aortic valves in P2Cre Tie1flox/lz mice 
were nearly twice the size as what was measured in Tie1flox/flox animals.  No differences 
in valve area were observed in the pulmonary valve (Fig 3.2 B) or in the AV valves.   
 
Tie1 does not appear to be involved in endothelial cell survival in the developing valve 
leaflet  
 Tie1 has been shown to be essential for endothelial survival and quiescence in the 
vasculature (Puri MC et al., 1995; Sato TN et al., 1995) therefore we first sought to 
examine P2Cre Tie1flox/lz valves for a loss of endothelial cells or endothelial cell integrity.  
The endothelial cell marker PECAM-1 did not show any differences in staining patterns 
or intensity in P2Cre Tie1flox/lz vs. Tie1 flox/flox valves (Fig. 3.3 A-F), suggesting that the 
endothelium was indeed present in these valves.  We also used the tight junction marker 
ZO1 (Fig. 3.3 I, J) and again concluded that endothelial cells in the valve leaflets were 
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Figure 3.1.  Tie1 deletion in the valve endocardium results in decreased survival rates.  
(A) As described, P2Cre Tie1flox/lz mice were  generated by crossing Tie1flox/lz mice to 
P2Cre Tie1flox/flox mice.  Rather than having a typical 25% Mendelian cross, we note a 
decrease in survival of P2Cre Tie1flox/lz offspring (green).  (B) Tie1 is efficiently deleted 
in the embryonic valve leaflets, as well as in the adult. 
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Figure 3.2.  P2Cre Tie1flox/lz animals have enlarged valve phenotype.  (A) At E14.5 Tie1 
flox/flox aortic valves are indistinguishable from that of P2Cre Tie1flox/lz aortic valves.  
Following this stage, a significant increase in size can be noted.  This size difference has 
been quantitated (B).  Blue bar, Tie1flox/flox; Green, Tie1flox/lz; Red, P2Cre Tie1flox/lz.   p-
value compares Tie1 flox/flox with P2Cre Tie1flox/lz. 
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present and did form intact epithelial sheets. Furthermore, inspection of the valve leaflets 
with transmission EM showed no abnormalities in the presence or appearance of valvular 
endothelial cells (Fig 3.3 G, H).  No abnormalities were seen in overall cell number, 
proliferation or apoptosis rates within the valve leaflets, suggesting that abnormalities in 
these processes likely did not lead to the hyperplastic valve phenotype of P2Cre Tie1flox/lz 
mice.   
 
Abnormal calcium deposition is observed in P2Cre Tie1flox/lz adult mice 
 Von Kossa staining revealed that numerous calcium deposits were present in 
young (2-3 month) adult P2Cre Tie1flox/lz valve leaflets, whereas no calcium deposits 
were noted in Tie1flox/flox animals (Fig 3.4).  The significance of this finding has not yet 
been determined, however we speculate that a loss of Tie1 in the valve may alter other 
signaling pathways responsible for secreting or degrading calcium deposits.  I will 
discuss this observation further in Chapter IV.  
 
Extracellular matrix content and organization is altered in P2Cre Tie1flox/lz semilunar 
valves 
 We used Movat’s Pentachrome stain to assess the deposition and organization of 
ECM within the valve leaflet (Fig 3.5 A).  Deposition of GAGs (blue) was much greater 
in P2Cre Tie1flox/lz valves as compared to Tie1flox/flox.  Furthermore, intricate stratification 
of ECM components within the leaflet was not observed in P2Cre Tie1flox/lz mice.   
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Figure 3.3.  Valvular endothelial cells lacking Tie1 do survive and do maintain an 
intact epithelial sheet.  (A-F) PECAM-1 immunofluorescence.  Tie1flox/flox endothelial 
cells are indistinguishable from P2Cre Tie1flox/lz endothelial cells at P0 (A, D) and 
adulthood (B, C, E, F).  Transmission EM of Tie1flox/flox (G) and P2Cre Tie1flox/lz (H) 
endothelial cells also appear normal. Tight junctions and epithelial sheets are also found 
to be intact in both P2Cre Tie1flox/lz (J) and Tie1flox/flox valve leaflets (I) as visualized by 
ZO1 immunohistochemistry. 
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Figure 3.4.  Abnormal calcium deposits are seen in P2Cre Tie1flox/lz valves.  Normal 
Tie1flox/flox aortic valves have minimal calcium deposits (black spots) at 3 months of age 
(arrows).  Age matched P2Cre Tie1flox/lz valves, however have numerous calcium 
deposits . 
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 Quantitation of the amount of GAGs in the adult valve leaflets was done using a 
colormetric assay (Fig 3.5 B).  The amount of GAGs was increased in both aortic and 
pulmonary P2Cre Tie1flox/lz valves over that of both Tie1flox/flox and Tie1flox/lz.  Likewise, 
we measured collagen content and a similar trend was noted.  The amount of collagen in 
P2Cre Tie1flox/lz adult valves was decreased in both aortic and pulmonary valves in a 
dose-dependent manor (Fig 3.5 C).   
 An antibody stain against chondroitin sulfate, a GAG found in the valve leaflet, 
also revealed that valves lacking Tie1 are insufficient at effectively organizing the ECM.  
Rather than being localized in the interstitium on the arterial side of the leaflet, 
chondroitin sulfate in the P2Cre Tie1flox/lz valve is clustered in random locations 
throughout the leaflet (Fig. 3.6), including both arterial and ventricular regions.  
 
P2Cre Tie1flox/lz valves are structurally and functionally insufficient 
 Atomic force microscopy (AFM) measures the “stiffness” of tissue or polymers. 
Information is gathered by projecting a laser onto a cantilever.  This causes the tip on the 
underside of the cantilever to touch the underlying sample.  The laser is reflected back to 
a photodiode which processes the information gained by displacement of the cantilever 
and tip.  Using this feedback, an image is generated and a color scale represent stiffness 
measured in kPa.  In this study, we used AFM to assess the integrity or “stiffness” of the 
valve leaflet.  Stiffness of the adult Tie1flox/flox aortic valve measured at approximately 
500 kPa, whereas corresponding regions on P2Cre Tie1flox/lz aortic valve leaflets 
measured about 5-fold lower, close to 100 kPa (Fig 3.7 C).   This supports our GAG and  
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Figure 3.5.  Proteoglycan and Glycosaminoglycan content in valves lacking Tie1 is 
increased as collagen levels decrease.  GAG deposition (blue) appears to be increased in 
P2Cre Tie1flox/lz valves as shown by Movat’s Pentachrome stain (A).    Sulfated GAGs 
were measured using a colormetric assay from Biocolor (B).  A significant increase 
(p=0.004 and 0.002) in the amount of sulfated GAGs were noted in both P2Cre Tie1flox/lz 
aortic and pulmonary valves.  Collagen was also quantitated using a similar method from 
Biocolor.  (C) A significant decrease in collagen content was noted in both pulmonary 
(p=0.006) and aortic (p=0.002) P2Cre Tie1flox/lz valve leaflets as compared to Tie1flox/flox 
littermates.  12 valve leaflets were pooled per sample and all samples were performed in 
triplicate. 
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Figure 3.6.  Chondroitin sulfate organization is abnormal in P2Cre Tie1flox/lz valves.  
Chondroitin sulfate deposition is organized to the arterial side of the valve leaflet in the 
Tie1flox/flox adult animal.  Such organization is lost in P2Cre Tie1flox/lz valves.   
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collagen quantitation data that indicate that P2Cre Tie1flox/lz valves have less collagen and 
more proteoglycans in the leaflets, thus reducing the rigidity of the valve. 
To assess functionality of Tie1flox/flox and P2Cre Tie1flox/lz valve leaflets, 
echocardiograms were performed on adult animals (n=6 mice per genotype). Though 
overall heart rate was unchanged, P2Cre Tie1flox/lz mice showed significant changes in 
systolic volume, ejection fraction, fractional shortening and left ventricle mass (Table 
3.1).  These values correlate with valvular insufficiencies and ultimate heart failure.  In 
addition, 100% (6/6) of P2Cre Tie1flox/lz aortic valves showed some degree of aortic and 
pulmonary regurgitation (Fig. 3.8) whilst only 17% of Tie1flox/flox (1/6) displayed minor 
pulmonary regurgitation. 
Discussion 
 This chapter focused on the effects of Tie1 deletion in the pro-valve endocardium 
of the developing mouse embryo.  We demonstrated that Tie1 is an essential component 
of valve remodeling as a loss of Tie1 in valve endothelium resulted in embryonic and 
perinatal demise as well as enlarged valves that persisted through adulthood.  Endothelial 
cell survival and morphology appeared unperturbed in mutant animals, as visualized by 
PECAM-1, ZO1 and transmission EM.  Though Tie1 has a role in endothelial cell 
survival and quiescence in the developing vasculature, it does not appear that this is the  
case in the developing valve as endothelial cells are present and form intact epithelial 
sheets.   
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Figure 3.7  P2Cre Tie1flox/lz valves lack rigidity as measured by atomic force 
microscopy.  (A) Corresponding regions of aortic valve sections were examined and each 
region was imaged three times.  (B) Relative stiffness of P2Cre Tie1flox/lz valves is much 
lower than what is seen in Tie1 flox/flox valve leaflets.  (C) Graphical representation of 
P2Cre Tie1flox/lz and Tie1 flox/flox valve stiffness shown in B.  Tie1 flox/flox aortic valves are 
approximately 5-fold stiffer than P2Cre Tie1flox/lz aortic valves.   
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Figure 3.8 P2Cre Tie1flox/lz valves are functionally abnormal.  (A) Transverse 
depiction of the aortic valve.  (B) WT and (C) P2Cre Tie1flox/lz  aortic valves.  
Unidirectional blood flow exists in (B) (red) and regurgitation is shown in (C) (red and 
blue).  Doppler profile of (D) WT and (E) P2Cre Tie1flox/lz  aortic valves.  Regurgitation 
is seen in (E).  
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Table 3.1.  Echocardiogram statistics for Tie1flox/flox and P2Cre Tie1 flox/lz adult mice.   
Measurements taken from 3 month old female Tie1 flox/flox and P2Cre Tie1flox/lz mice.  
Asterisk denotes a p value of < 0.005.   
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 Deletion of Tie1 in the valve endocardium results in abnormally large 
hyperplastic aortic valves.  There are no changes in endothelial or mesenchymal 
proliferation or apoptosis in P2Cre Tie1flox/lz valves, nor are there significant changes in 
cell number. However, deposition and organization of numerous ECM components are 
disregulated in later stages.  Changes in ECM are noted in both pulmonary and aortic 
valves, though area measurements show a significant increase in aortic valve size.  We 
hypothesize that this phenomenon is due to the increased hemodynamic flow across the 
aortic valve and less physical stress on the pulmonary valve.  This change in flow occurs 
around birth when the ductus arteriosis closes, which coincides with the most dramatic 
increases in aortic valve size. 
 A close examination of the ECM revealed that not only the organization of matrix 
components was abnormal, but the amount of GAG and collagen deposition was 
abnormal as well.  As animals age, the collagen content of the valve typically increases as 
GAG content decreases.  Furthermore, periostin deposition is altered in P2Cre Tie1flox/lz  
mice.  Periostin is made and secreted by the mesenchyme, and because we deleted a gene 
in the endothelium, it is the endothelium that must be responsible for miscommunication.  
In P2Cre Tie1flox/lz valves, the matrix never receives the proper message to make the 
switch from GAG filled valve leaflets to fully remodeled leaflets with a higher collagen 
content, suggesting that Tie1 plays a role in crosstalk between endothelium and 
mesenchyme in the embryonic and post-natal remodeling valve leaflet. A lack of Tie1 in 
the valve endocardium disrupts this crosstalk, therefore disrupting the process of valve 
remodeling.  This may be in part due to the loss of Tie1 expression itself, as in the adult 
Tie1 is typically localized to the arterial side of the valve leaflet.  A loss of this 
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expression pattern may also cause miscommunication within the leaflet in terms of 
knowing which “side” of the valve is arterial and which side is ventricular.   
 Not only do we observe molecularly based anomalies in aortic valve size and 
ECM organization, P2Cre Tie1flox/lz valves are functionally insufficient as well.  AFM 
data confirm, as we suspected, that P2Cre Tie1flox/lz valves containing high levels of 
GAGs and lower levels of collagens are physically “softer” and less rigid than that of 
Tie1flox/flox leaflets.  Echocardiograms of adult P2Cre Tie1flox/lz and Tie1flox/flox mice 
indicate that the less rigid valves as indicated by the AFM correlates with insufficient 
valve function in mice lacking Tie1 in the valve endocardium, likely leading to eventual 
heart failure.  One hundred percent of the P2Cre Tie1flox/lz mice (n=6) examined by 
echocardiogram showed some degree of both pulmonary and aortic valve regurgitation 
whereas only 17% of Tie1flox/flox mice had minor pulmonary regurgitation.  The degree of 
insufficiency varied within P2Cre Tie1flox/lz mice, ranging from mild regurgitation to 
more severe regurgitation reaching the aortic arch and abdominal aorta.  We are the first 
to show that Tie1 plays a role outside the vasculature of the developing embryo and that  
cell-cell communication between endothelium and the mesenchyme are critical during 
valve development.   
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CHAPTER IV 
 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
 The major focus of this work was to identify a role for Tie1 in the developing 
valve.  Most global Tie1 knockouts do live long enough to develop valves that undergo 
remodeling (Sato TN et al., 1995).  Of the few Tie1-/- mice that do survive to E14.5, early 
in the valve remodeling process, the focus has been on the more obvious vascular 
phenotype and the valves are not examined in depth.  Little information on Tie1 has been 
documented in the literature, and the majority of those studies have been done in vitro 
under extraordinary conditions that are mostly unrelated to real events in vivo.  This study 
was an important step away from the previous in vitro studies and a step closer to 
identifying what Tie1’s role is in the developing murine embryo.   
The secondary focus of this work has been to describe the role of the NFATc1-
P2Cre as a tool that can be used to study later stages of valve remodeling.  Using the 
P2Cre, we are now able to examine the role of vascular endothelial genes in the 
developing valve. Global deletions of vascular endothelial genes resulting in early 
embryonic lethality has, until now, made such studies unattainable.  
  
The origin of adult valvular endothelial cells 
 The origin of cells in the adult heart valve has been a topic of discussion in the 
field for many years.  Cells of the adult valve endocardium must either arise from 
embryonic endocardium, mesenchyme-endothelial cell transformation from cells of the 
valve interstitium, or from circulating progenitor cells. Proliferation and apoptosis rates 
 61 
in VICs and VECs are quite low in the adult valve, so the question has always been 
whether these cells are replaced by other sources, such as circulating progenitor cells.  As 
discussed in Chapter I, Visconti et al used a green fluorescent marker to label 
hematopoietic stem cells and implanted them into lethally irradiated mice.  Upon 
dissection, it was found that green fluorescent cells were present in the valve interstitium 
and analysis of those cells displayed markers and demonstrated a function similar to that 
of mature VICs (Visconti RP, 2006).   It is important to note that no green fluorescent 
cells were observed contributing to the endothelium of the valve leaflet.  So where do the 
endothelial cells of the adult valve come from?  Using the NFATc1-P2Cre, and an R26R 
reporter we are able to label the valve endothelial cells in the early embryo and observe 
the progression of these cells through development into adulthood.  We have noted that 
the majority of endothelial cells lining the adult heart valve retain R26R expression even 
though the P2Cre is turned off after E14.5.  In addition, no R26R expressing cells are 
ever seen in the valve interstitium.  From these data, we conclude that the endothelial 
cells present in the early developing embryo are the same cells that are maintained 
through adulthood.  These endothelial cells do not become replaced by circulating EPCs 
or cells of mesenchymal or other origins.  This finding will without a doubt change the 
way that we think about the valve endothelium. 
 
Tie1 is essential for late-gestational semilunar valve remodeling 
 At E8.5, Tie1 is the last RTK to be turned on during vasculature development.  
Global knockouts of Tie1 result in a breakdown of the microvasculature, edema and 
eventual embryonic demise around E14.5 (Puri MC et al., 1995; Sato TN et al., 1995).  
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Tie1 is highly expressed in the heart and developing valve leaflets during embryonic 
development, however no heart or valve phenotype was noted in the global knockout 
papers.  Using the NFATc1-P2Cre, we were able to delete a conditional Tie1 floxed 
allele in the pro-valve endocardium of the developing heart, therefore bypassing the 
requirement for Tie1 in vasculature.  P2Cre Tie1flox/lz mice do not survive in expected 
ratios and closer examination revealed that these animals have larger aortic valves as 
compared to Tie1flox/flox littermates.  No size difference was noted in the pulmonary 
valves of these mice, which may be attributed to the differences in hemodynamic flow in 
the left heart vs. right heart after closure of the ductus arteriosis.  The mitral and tricuspid 
valves also appear unaffected. 
 Endothelial cells lacking Tie1 in the valve leaflet survive and maintain intact 
epithelial sheets.  This is in direct contrast to what is observed in other endothelial cell 
models in which Tie1 expression is lost.  Previous studies of Tie1 in the vasculature or in 
vasculature cell lines have indicated that Tie1 is essential for endothelial survival 
(Partanen J et al., 1992; Puri MC et al., 1995; Sato TN et al., 1995).  Our data show that 
the role of Tie1 in the endothelium is context dependent and that Tie1 is essential for 
functions other than basic endothelial survival in the valve.   
 A loss of Tie1 in the developing valve appears to have the most severe effect on 
organization and deposition of ECM within the leaflet (Fig. 4.2).  We provide data that 
suggests this process is dose-dependent, and mice with one functional Tie1 allele 
(Tie1flox/lz) display an intermediate phenotype when examining GAG and collagen 
content in the valve, even though these valves look and function physically similar to 
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Tie1flox/flox valves.  Aortic valve size is also dose dependent, as Tie1flox/lz aortic valve area 
measures between that of Tie1flox/flox and P2Cre Tie1flox/lz. 
 Numerous immunohistochemical stains and other assays indicate that the ECM 
makeup in the valve leaflets of P2Cre Tie1flox/lz mice is abnormal, but does that translate 
to a functional insufficiency?  Using AFM, we determined that the excess GAG content 
in these valves leads to a lack of stiffness and rigidity.  This observation is confirmed by 
echocardiogram.  Functional analysis of valves lacking Tie1 show that the 
disorganization of valvular ECM and the delay in remodeling leads to aortic and 
pulmonary regurgitation in 100% of P2Cre Tie1flox/lz animals that were examined.  
Valvular insufficiency leading to aortic stenosis and cardiac regurgitation is likely the 
cause of death in P2Cre Tie1flox/lz mice.  Again, we speculate that this is based on the 
amount of Tie1 that is deleted in the valve.  The P2Cre is not 100% efficient, and it is 
possible that some of the variability in the phenotype that we see in P2Cre Tie1flox/lz mice 
is due to fluctuating amounts of residual Tie1 expression that was not fully deleted by the 
P2Cre.  This may be one explanation as to why only half of the P2Cre Tie1flox/lz mice die, 
while the other half survive through adulthood.   
 We hypothesize that Tie1 plays a role in cell-cell communication between the 
endothelium and underlying mesenchyme, and are the first to suggest that such a 
communication exists and is essential for appropriate valve remodeling.  Native Tie1 in 
the adult is expressed on the arterial side of the valve leaflet in areas of turbulent flow. 
We also suggest that a loss of Tie1 on the arterial side of the valve in P2Cre Tie1flox/lz 
mice can lead to further miscommunication as Tie1 may be a directional signal that 
guides the ECM into proper position during remodeling.   
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Tie2/Ang1 has been implicated in endothelial-mesenchymal communications in 
the developing vasculature (Chitra Suri 1996).   Endothelial cell migrations and vessel 
formation require precise cell-cell and cell-matrix interactions.   Decreased association of 
endothelial/smooth muscle cells and the underlying matrix has been reported in the 
vasculature of Ang1 null animals. A few studies have made direct links between 
angiopoietins and factors that control endothelial cell survival, migration, morphogenesis 
and communicative signals (Bazzoni, 1999). We speculate that Tie1 may signal through 
Tie2/Ang1 in the developing valve to communicate with the underlying matrix.   
 
Future Directions 
Since no definitive ligand has been identified for Tie1, studies of downstream signaling 
targets have been lacking in the literature.  Furthermore, the only studies that provide 
insight into Tie1 signaling targets have arisen from  in vitro models.  Using tissue from 
P2Cre Tie1flox/lz mice, we hope to first determine the in vivo relationship between Tie1 
and Tie2 in the valve leaflet. A recent paper sought to examine the interactions between 
Tie1 and Tie2 in vitro (Kim KL SI, 2006).  This group looked at expression levels of both 
Tie1 and Tie2 in endothelial progenitor cells (EPCs) and in HUVECs and found similar 
levels of expression in each cell type.  Tie1 was found to associate with Tie2 in the 
mature cell type (HUVECs) but not in EPCs, suggesting that Tie1’s role in development 
is not only spatially but temporally context-dependent.  In addition, Tie1-Tie2 
heterocomplexes inhibit Ang2 from binding and activating Tie2 signaling in HUVEC’s. 
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Figure 4.1.  Potential interaction between Tie1 and Tie2 RTKs. Tie1 and Tie2 may 
interact to activate downstream signaling during valve remodeling.  It is unknown if Tie1 
can homodimerize and signal in the absence of Tie2. 
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Figure 4.2.  Abnormal remodeling of P2Cre Tie1flox/lz valves.  Depiction of normal valve 
development and remodeling, and a representation of normal mature valve leaflets as 
compared to P2Cre Tie1flox/lz valves.  Note that ECM organization is disregulated. 
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More work needs to be done in this area to determine if similar events take place in vivo. 
We will examine levels of Tie2 phosphorylation in P0 Tie1flox/flox and P2Cre Tie1flox/lz 
valves to determine if an interaction between these receptors exist in this context. If Tie1 
signals through Tie2, then we might expect that there will be changes in Tie2 
phosphorylation due to a loss of Tie1.  Conversely, if Tie1 signaling is independent of 
Tie2 in the remodeling heart valve then we would anticipate no alterations in Tie2 
phosphorylation when Tie1 is deleted in the valves (Fig. 4.1).  Preliminary results suggest 
that Tie1 is signaling through Tie2 in the developing valve, as Western blot analysis 
suggests that a loss of Tie1 in the valve endocardium leads to an increase in Tie2 
phosphorylation. These data suggest that Tie1 may be responsible for repressing Tie2 
activation in this context. 
We are currently generating Tie2flox/flox mice in our laboratory using BAC 
recombineering.  The Tie2flox construct contains loxP sites flanking the minimal promoter 
region, exon1 and a region of intron1.  The construct is completed and is currently being 
injected into blastocysts to generate stable lines.  We can use these animals to generate 
mice that lack both Tie1 and Tie2 (P2Cre Tie1flox/lz Tie2flox/-) in the valve endocardium 
and determine if a genetic interaction exists between these two receptor tyrosine kinases 
in this context.  We anticipate that an interaction exists between Tie1 and Tie2 in the 
context of the developing valve, therefore double knockouts of the Tie receptors in the 
valve will likely exacerbate the valve phenotype that we observe in the P2Cre Tie1flox/lz 
animals. 
  Furthermore, downstream targets of Tie1 signaling must be identified.  
Tie1flox/flox and P2Cre Tie1flox/lz valve tissue has been sent to collaborators for RNA 
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sequencing analysis.  We hope that comparisons between the two tissues will provide 
insight into previously unknown regulatory networks not only for Tie1 but also for 
normal valve remodeling.  We will also be able to make comparisons between wild type 
pulmonary and aortic valves to determine fundamental differences between these two 
seeming similar tissues. 
 We briefly discussed abnormal calcium deposits in 2-3 month old P2Cre Tie1flox/lz 
valves in Chapter III.  We have examined deposition of osteopontin and osteoprotegrin in 
these valves and have found no differences between Tie1flox/flox and P2Cre Tie1flox/lz 
valves at any point in development.  It is not certain if Tie1 directly regulates pathways 
involving calcium deposition, or if this is a secondary effect as a result of already 
weakened valve tissue.  The increase in calcium deposition, however, likely contributes 
to the valvular insufficiency seen in the echocardiograms.   
 In summary, we have provided evidence to show that Tie1 is highly expressed in 
the developing heart valve. Aortic valve leaflets lacking Tie1 are larger than Tie1flox/flox 
leaflets, and more than half of P2Cre Tie1flox/lz animals die, likely due to valvular 
insufficiencies as a result of abnormal ECM deposition and deficient valve remodeling.  
We hypothesize that Tie1 is essential for proper cell-cell communication and that this 
communication may involve Tie2 signaling. The localization of Tie1 to the arterial side 
of the valve in the adult suggests that Tie1 may act to relay spatial-temporal information 
to the underlying mesenchyme.  Alterations in this communication mechanism may be 
what results in insufficient ECM stratification.  The identification of gene regulatory 
networks associated with Tie1 signaling and valve remodeling will aid in future efforts to 
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generate a bio-engineered heart valve that will have the potential to grow and remodel 
with patients who are not candidates for typical artificial valve replacements. 
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